TRPC5 and renal cell carcinoma: An analogue of the xanthine-based Pico145 inhibitor, AM237 at 15 to 20 nM, activates TRPC5 in the A498 RCC line and potentiates TRPC5 activation by sphingosine-1-phosphate.